InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Tuesday, 04/03/2018 8:32:53 AM

Tuesday, April 03, 2018 8:32:53 AM

Post# of 345969
From 01 2018 - Old???

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

https://www.dovepress.com/a-combination-of-p53-activating-apr-246-and-phosphatidylserine-targeti-peer-reviewed-article-BCTT

and:

Combination Breast Cancer Therapy Targets Both Tumor Cells and the Blood Vessels That Supply Them

https://www.dddmag.com/news/2018/03/combination-breast-cancer-therapy-targets-both-tumor-cells-and-blood-vessels-supply-them
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News